SCHEMBL7269335

SCHEMBL7269335

CC1SC(=O)NN=C1c1ccc2c(c1)C(=NNc1ccc(C(=O)O)cc1)C(=O)N2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 9/20 0.46
PDE3A Q14432 9/20 0.46
PDE4A P27815 6/20 0.46
PDE4B Q07343 6/20 0.46
PDE4C Q08493 6/20 0.46
PDE4D Q08499 6/20 0.46
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
GAA P10253 1/20 0.37
KCNH2 Q12809 1/20 0.36
FBP1 P09467 1/20 0.34
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAP3K7 O43318 1/20 0.32
TAB1 Q15750 1/20 0.32
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
NOX1 Q9Y5S8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7267327 0.90 PDE3B (0.49) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7276028 0.89 PDE3B (0.48) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7269474 0.88 PDE4A (0.48) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7276125 0.88 PDE3B (0.48) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7267004 0.86 PDE3B (0.46) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7267008 0.86 PDE3B (0.46) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7273763 0.86 PDE3B (0.46) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9876327 0.86 PDE3B (0.46) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9876328 0.86 PDE3B (0.46) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9879907 0.85 PDE3B (0.46) PDE3BPDE3APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5051417-A Indolythiadiazines for treating heart failure LES LABORATOIRES BEECHAM S.A. (FR) 1991-09-24 US claimed
EP-0351213-A2 2-Indolones substituted in 5 by a cyclic hydrazide radical, their preparation and their use in cardio-active medicaments LES LABORATOIRES BEECHAM S.A. (FR) 1990-01-17 EP claimed